176 related articles for article (PubMed ID: 19732732)
1. Metronomic chemotherapy.
Mutsaers AJ
Top Companion Anim Med; 2009 Aug; 24(3):137-43. PubMed ID: 19732732
[TBL] [Abstract][Full Text] [Related]
2. Low-dose cyclophosphamide selectively decreases regulatory T cells and inhibits angiogenesis in dogs with soft tissue sarcoma.
Burton JH; Mitchell L; Thamm DH; Dow SW; Biller BJ
J Vet Intern Med; 2011; 25(4):920-6. PubMed ID: 21736624
[TBL] [Abstract][Full Text] [Related]
3. Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas.
Elmslie RE; Glawe P; Dow SW
J Vet Intern Med; 2008; 22(6):1373-9. PubMed ID: 18976288
[TBL] [Abstract][Full Text] [Related]
4. Metronomic chemotherapy in veterinary patients with cancer: rethinking the targets and strategies of chemotherapy.
Biller B
Vet Clin North Am Small Anim Pract; 2014 Sep; 44(5):817-29. PubMed ID: 25174901
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant anthracycline-based vs metronomic chemotherapy vs no medical treatment for dogs with metastatic splenic hemangiosarcoma: A multi-institutional retrospective study of the Italian Society of Veterinary Oncology.
Marconato L; Chalfon C; Finotello R; Polton G; Vasconi ME; Annoni M; Stefanello D; Mesto P; Capitani O; Agnoli C; Amati M; Sabattini S
Vet Comp Oncol; 2019 Dec; 17(4):537-544. PubMed ID: 31251441
[TBL] [Abstract][Full Text] [Related]
6. Metronomic chemotherapy for cancer treatment: a decade of clinical studies.
Romiti A; Cox MC; Sarcina I; Di Rocco R; D'Antonio C; Barucca V; Marchetti P
Cancer Chemother Pharmacol; 2013 Jul; 72(1):13-33. PubMed ID: 23475105
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of thrombospondin-1 mimetic peptides, ABT-510 and ABT-898, in dogs with soft tissue sarcoma.
Sahora AI; Rusk AW; Henkin J; McKeegan EM; Shi Y; Khanna C
J Vet Intern Med; 2012; 26(5):1169-76. PubMed ID: 22816494
[TBL] [Abstract][Full Text] [Related]
8. HYPOFRACTIONATED RADIOTHERAPY FOR MACROSCOPIC CANINE SOFT TISSUE SARCOMA: A RETROSPECTIVE STUDY OF 50 CASES TREATED WITH A 5 × 6 GY PROTOCOL WITH OR WITHOUT METRONOMIC CHEMOTHERAPY.
Cancedda S; Marconato L; Meier V; Laganga P; Roos M; Leone VF; Rossi F; Bley CR
Vet Radiol Ultrasound; 2016 Jan; 57(1):75-83. PubMed ID: 26551348
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic treatment of breast cancer using metronomic low-dose chemotherapy.
Munoz R; Shaked Y; Bertolini F; Emmenegger U; Man S; Kerbel RS
Breast; 2005 Dec; 14(6):466-79. PubMed ID: 16199161
[TBL] [Abstract][Full Text] [Related]
10. [Metronomic chemotherapy: a new approach in cancer therapy].
Bujak A; Kałas W
Postepy Hig Med Dosw (Online); 2008 Jul; 62():364-71. PubMed ID: 18688207
[TBL] [Abstract][Full Text] [Related]
11. Metronomic dosing of chemotherapy: applications in pediatric oncology.
Stempak D; Seely D; Baruchel S
Cancer Invest; 2006; 24(4):432-43. PubMed ID: 16777697
[TBL] [Abstract][Full Text] [Related]
12. [Metronomic chemotherapy in pediatric oncology: hype or hope?].
André N; Pasquier E; Verschuur A; Sterba J; Gentet JC; Rössler J
Arch Pediatr; 2009 Aug; 16(8):1158-65. PubMed ID: 19446445
[TBL] [Abstract][Full Text] [Related]
13. Metronomic chemotherapy: Back to the future!
André N; Padovani L; Verschuur A
Drug News Perspect; 2010 Mar; 23(2):143-51. PubMed ID: 20369080
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
Drevs J; Fakler J; Eisele S; Medinger M; Bing G; Esser N; Marmé D; Unger C
Anticancer Res; 2004; 24(3a):1759-63. PubMed ID: 15274352
[TBL] [Abstract][Full Text] [Related]
15. Metronomic therapy for gynecologic cancers.
Su WH; Ho TY; Li YT; Lu CH; Lee WL; Wang PH
Taiwan J Obstet Gynecol; 2012 Jun; 51(2):167-78. PubMed ID: 22795090
[TBL] [Abstract][Full Text] [Related]
16. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
Kerbel RS
Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
[TBL] [Abstract][Full Text] [Related]
17. Rationale for the use of metronomic chemotherapy in gastrointestinal cancer.
Filippi R; Lombardi P; Depetris I; Fenocchio E; Quarà V; Chilà G; Aglietta M; Leone F
Expert Opin Pharmacother; 2018 Sep; 19(13):1451-1463. PubMed ID: 30161003
[TBL] [Abstract][Full Text] [Related]
18. The use of low-dose metronomic chemotherapy in dogs-insight into a modern cancer field.
Gaspar TB; Henriques J; Marconato L; Queiroga FL
Vet Comp Oncol; 2018 Mar; 16(1):2-11. PubMed ID: 28317239
[TBL] [Abstract][Full Text] [Related]
19. Metronomic chemotherapy for advanced breast cancer patients.
Cazzaniga ME; Dionisio MR; Riva F
Cancer Lett; 2017 Aug; 400():252-258. PubMed ID: 28017894
[TBL] [Abstract][Full Text] [Related]
20. [A new treatment protocol targeting tumor vasculature--- metronomic chemotherapy combined radiotherapy].
Qiu H; Wang GM
Ai Zheng; 2007 Dec; 26(12):1392-6. PubMed ID: 18076810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]